Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 96

References for PMC Articles for PubMed (Select 16855216)

1.

p44 mitogen-activated protein kinase (extracellular signal-regulated kinase 1)-dependent signaling contributes to epithelial skin carcinogenesis.

Bourcier C, Jacquel A, Hess J, Peyrottes I, Angel P, Hofman P, Auberger P, Pouysségur J, Pagès G.

Cancer Res. 2006 Mar 1;66(5):2700-7.

2.

Actin cytoskeleton of rabbit intestinal cells is a target for potent marine phycotoxins.

Ares IR, Louzao MC, Vieytes MR, Yasumoto T, Botana LM.

J Exp Biol. 2005 Nov;208(Pt 22):4345-54.

4.

From JNK to pay dirt: jun kinases, their biochemistry, physiology and clinical importance.

Karin M, Gallagher E.

IUBMB Life. 2005 Apr-May;57(4-5):283-95. Review.

PMID:
16036612
5.
6.

Stress-activated protein kinases-tumor suppressors or tumor initiators?

Engelberg D.

Semin Cancer Biol. 2004 Aug;14(4):271-82. Review.

PMID:
15219620
7.

Mitogen-activated protein kinase phosphatase-3 is a tumor promoter target in initiated cells that express oncogenic Ras.

Warmka JK, Mauro LJ, Wattenberg EV.

J Biol Chem. 2004 Aug 6;279(32):33085-92. Epub 2004 May 24.

8.

Structure and regulation of MAPK phosphatases.

Farooq A, Zhou MM.

Cell Signal. 2004 Jul;16(7):769-79. Review.

PMID:
15115656
9.

Inducible expression of a MAP kinase phosphatase-3-GFP chimera specifically blunts fibroblast growth and ras-dependent tumor formation in nude mice.

Marchetti S, Gimond C, Roux D, Gothié E, Pouysségur J, Pagès G.

J Cell Physiol. 2004 Jun;199(3):441-50.

PMID:
15095291
10.

Tumor promoter-induced MMP-13 gene expression in a model of initiated epidermis.

Zeliadt NA, Warmka JK, Winston SE, Kahler R, Westendorf JJ, Mauro LJ, Wattenberg EV.

Biochem Biophys Res Commun. 2004 Apr 30;317(2):570-7.

PMID:
15063796
11.
12.
13.

Molecular mechanisms of Na/K-ATPase-mediated signal transduction.

Xie Z.

Ann N Y Acad Sci. 2003 Apr;986:497-503. Review.

PMID:
12763870
14.

Potential tumor suppressive pathway involving DUSP6/MKP-3 in pancreatic cancer.

Furukawa T, Sunamura M, Motoi F, Matsuno S, Horii A.

Am J Pathol. 2003 Jun;162(6):1807-15.

15.

A pivotal role for ERK in the oncogenic behaviour of malignant melanoma?

Smalley KS.

Int J Cancer. 2003 May 1;104(5):527-32. Review.

PMID:
12594806
16.

Na+/K+-pump ligands modulate gating of palytoxin-induced ion channels.

Artigas P, Gadsby DC.

Proc Natl Acad Sci U S A. 2003 Jan 21;100(2):501-5. Epub 2002 Dec 23.

17.

Targeting RAS signalling pathways in cancer therapy.

Downward J.

Nat Rev Cancer. 2003 Jan;3(1):11-22. Review.

PMID:
12509763
18.

Mitogen-actived protein kinase activation is an early event in melanoma progression.

Cohen C, Zavala-Pompa A, Sequeira JH, Shoji M, Sexton DG, Cotsonis G, Cerimele F, Govindarajan B, Macaron N, Arbiser JL.

Clin Cancer Res. 2002 Dec;8(12):3728-33.

19.

Extracellular signal-regulated kinase transmits palytoxin-stimulated signals leading to altered gene expression in mouse keratinocytes.

Warmka JK, Winston SE, Zeliadt NA, Wattenberg EV.

Toxicol Appl Pharmacol. 2002 Nov 15;185(1):8-17.

PMID:
12460732
20.

Action of palytoxin on apical H+/K+-ATPase in rat colon.

Scheiner-Bobis G, Hübschle T, Diener M.

Eur J Biochem. 2002 Aug;269(16):3905-11.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk